In this paper, a case with severe respiratory distress syndrome recovering after 5 doses of surfactant administration is presented, and multiple dose surfactant administration which is rarely required in this disease is also discussed.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Although surfactant has been one of the basic treatment approaches in respiratory distress syndrome in the last 20 years, an absolute consensus has not been established regarding its way of use and dosing regimens.
📊
Key Findings & Data:Although surfactant has been one of the basic treatment approaches in respiratory distress syndrome in the last 20 years, an absolute consensus has not been established regarding its way of use and dosing regimens.
💡
Conclusion & Impact:In this paper, a case with severe respiratory distress syndrome recovering after 5 doses of surfactant administration is presented, and multiple dose surfactant administration which is rarely required in this disease is also discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Although surfactant has been one of the basic treatment approaches in respiratory distress syndrome in the last 20 years, an absolute consensus has not been established regarding its way of use and dosing regimens. In this paper, a case with severe respiratory distress syndrome recovering after 5 doses of surfactant administration is presented, and multiple dose surfactant administration which is rarely required in this disease is also discussed.
Özet
Surfaktan kullanımı son 20 yılda respiratuvar distres sendromunun temel tedavi yaklaşımlarından birisi olmasına rağmen, kullanım şekli ve dozu konusunda kesin bir fikir birliği oluşmamıştır. Bu yazıda 5 doz surfaktan kullanımı sonrası düzelme gösteren ağır respiratuvar distres sendromlu bir olgu sunularak, bu hastalıkta nadir başvurulan çoklu doz surfaktan uygulamasının literatür eşliğinde tartışılması amaçlanmıştır.
🔖
Cite This Article
CANER, İ., SARICI, S. Ü., SARI, E., ERDEVE, Ö. (2022). Severe respiratory distress syndrome required multiple doses of surfactant administration: A rare case report. Erciyes Tıp Dergisi, Cilt: 30 - Sayı: 4, 292–296. https://ajindex.com/articles/502679
Rodriguez RJ. Management of respiratory distress syndrome: an update. Respir Care 2003; 48:279-286
Ainsworth SB. Pathophysiology of neonatal respiratory distress syndrome: implications for early treatment strategies. Treat Respir Med 2005; 4:423-437
Suresh GK, Soll RF. Current surfactant use in premature infants. Clin Perinatol 2001; 28:671-694
Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994; 330:1476-1480
Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; (2):CD000141
Suresh GK, Soll RF. Exogenous surfactant therapy in newborn infants. Ann Acad Med Singapore 2003; 32:335-345 7) Sweet D, Bevilacqua G, Carnielli V, et al. Working Group on Prematurity of the World Association of Perinatal Medicine, European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007; 35:175-186
Yurdakök M. Inherited disorders of neonatal lung diseases. Turk J Pediatr 2004;46:105-114
Cole FS, Hamvas A, Rubinstein P, et al. Population- based estimates of surfactant protein B deficiency. Pediatrics 2000; 105:538-541
Sarıcı SÜ, Yurdakök M, Naçar N, Korkmaz A, Yiğit Þ, Tekinalp G. Yenidoğan bebeklerde respiratuvar distres sendromunun tedavisinde iki farklı doğal surfaktan preparatının etkinliklerinin karşılaştırılması. Çocuk Sağlığı ve Hastalıkları Dergisi 2004; 47;161-166
Verlato G, Cogo PE, Benetti E, Gomirato S, Gucciardi A, Carnielli VP. Kinetics of surfactant in respiratory diseases of the newborn infant. J Matern Fetal Neonatal Med 2004;16 suppl 2:21-24
Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; (2):CD001456.